SAVA
ANALYST COVERAGE12 analysts
BUY
Buy
867%
Hold
433%
8 Buy (67%)4 Hold (33%)0 Sell (0%)
Full report →
PRICE
Prev Close
1.99
Open
1.97
Day Range1.95 – 2.03
1.95
2.03
52W Range1.15 – 4.98
1.15
4.98
21% of range
VOLUME & SIZE
Avg Volume
857.8K
FUNDAMENTALS
P/E Ratio
-0.9x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.09
Market-like
TECHNICAL
RSI (14)
65
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 159 days
Oct 27

SAVA News

About

refer to descriptions included in the company's filings with the securities and exchange commission for more information about the company. the company does not intend to update and does not take responsibility for any information published on linkedin.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Remi Barbier
George ThorntonSenior Vice President of Technology
Jaren LandenChief Clinical Development Officer
Angélique BordeySenior Vice President of Neuroscience
Joseph HulihanChief Medical Officer
Eric J. SchoenChief Financial Officer
Jack MooreSenior Vice President of Clinical Development
Michael ZamlootSenior Vice President of Technical Operations
Christopher CookChief Operating & Legal Officer
Richard Jon BarryChief Executive Officer, President & Director
Freda NassifChief Business Officer & Chief Commercial Officer